Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?

Affiliations

¹ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK.
² Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK. Electronic address: belinda.lennox@psych.ox.ac.uk.

Comment

Jack B Fanshawe et al. Lancet Psychiatry. 2024 Jun.

. 2024 Jun;11(6):400-402.

doi: 10.1016/S2215-0366(24)00140-8. Epub 2024 Apr 30.

¹ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK.
² Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK. Electronic address: belinda.lennox@psych.ox.ac.uk.

No abstract available

Conflict of interest statement

BRL is the vice chair of the Psychopharmacology Committee of the Royal College of Psychiatrists. JBF declares no competing interests.

Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland.
Rubio JM, Kane JM, Tanskanen A, Tiihonen J, Taipale H. Rubio JM, et al. Lancet Psychiatry. 2024 Jun;11(6):443-450. doi: 10.1016/S2215-0366(24)00097-X. Epub 2024 Apr 30. Lancet Psychiatry. 2024. PMID: 38697177